Rocket Pharmaceuticals, Inc. (RCKT) Insider Trading
Over the last 3 months, RCKT insiders made 0 open-market buys and 8 sales, a net sale of -$275K (SEC Form 4). Over the last 6 months, 151 institutions increased and 127 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
8
Net (3m)
-$275.0K
Insider trades by month Buys Sells
Aug
Oct
Nov
Jan
Feb
May
Context3-month price -39.4%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| May 28, 2026 | Militello Johnofficer: See Remarks | Grant | 51,509 | $3.00 |
| May 28, 2026 | Militello Johnofficer: See Remarks | Grant | 15,002 | $3.00 |
| May 28, 2026 | Militello Johnofficer: See Remarks | Grant | 9,091 | $3.00 |
| May 28, 2026 | Militello Johnofficer: See Remarks | Grant | 16,061 | $3.00 |
| May 28, 2026 | Militello Johnofficer: See Remarks | Grant | 24,899 | $3.00 |
| May 26, 2026 | Shah Gauravofficer: CEO | Sell | 55,684 | $3.09 |
| May 26, 2026 | Shah Gauravofficer: CEO | Option | 76,490 | $1.69 |
| May 21, 2026 | Militello Johnofficer: See Remarks | Sell | 384 | $3.01 |
| May 21, 2026 | Shah Gauravofficer: CEO | Sell | 2,409 | $3.01 |
| May 21, 2026 | Wilson Martinofficer: General Counsel | Sell | 662 | $3.01 |
| May 14, 2026 | Shah Gauravofficer: CEO | Sell | 2,728 | $3.61 |
| May 14, 2026 | Militello Johnofficer: See Remarks | Sell | 855 | $3.61 |
| May 14, 2026 | Wilson Martinofficer: General Counsel | Sell | 3,361 | $3.61 |
| May 11, 2026 | Chaudhuri Sarbaniofficer: See Remarks | Sell | 17,650 | $3.84 |
| Feb 20, 2026 | Wilson Martinofficer: General Counsel | Sell | 1,376 | $3.34 |
| Feb 20, 2026 | Militello Johnofficer: See Remarks | Sell | 1,157 | $3.34 |
| Feb 20, 2026 | Shah Gauravofficer: CEO | Sell | 5,990 | $3.34 |
| Feb 18, 2026 | Shah Gauravofficer: CEO | Sell | 12,279 | $3.31 |
| Feb 18, 2026 | Wilson Martinofficer: General Counsel | Sell | 12,253 | $3.31 |
| Feb 18, 2026 | Militello Johnofficer: See Remarks | Sell | 3,726 | $3.31 |
| Feb 13, 2026 | Chaudhuri Sarbaniofficer: See Remarks | Grant | 125,924 | — |
| Feb 13, 2026 | Militello Johnofficer: See Remarks | Grant | 29,982 | — |
| Feb 13, 2026 | Stevens Christopher Jamesofficer: Chief Operating Officer | Grant | 93,037 | $3.24 |
| Feb 13, 2026 | Stevens Christopher Jamesofficer: Chief Operating Officer | Grant | 61,963 | — |
| Feb 13, 2026 | Rizvi Syed Ali-aamirofficer: Chief Medical Officer | Grant | 93,037 | $3.24 |
| Feb 13, 2026 | Shah Gauravofficer: CEO | Grant | 870,648 | $3.24 |
| Feb 13, 2026 | Rizvi Syed Ali-aamirofficer: Chief Medical Officer | Grant | 61,963 | — |
| Feb 13, 2026 | Wilson Martinofficer: General Counsel | Grant | 468,187 | $3.24 |
| Feb 13, 2026 | Shah Gauravofficer: CEO | Grant | 286,028 | — |
| Feb 13, 2026 | Wilson Martinofficer: General Counsel | Grant | 311,813 | — |
Source: RCKT SEC Form 4 filings, latest May 28, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their RCKT positions over the last 6 months (SEC Form 13F).
Increased
151
New positions
66
Reduced
127
Sold out
51
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| RTW INVESTMENTS, LP | Unchanged | 17.7M | May 15, 2026 |
| RTW INVESTMENTS, LP | Unchanged | 17.7M | Feb 17, 2026 |
| VANGUARD GROUP INC | Increased | 8.5M | Jan 29, 2026 |
| BLACKROCK, INC. | Increased | 7.9M | Feb 12, 2026 |
| BLACKROCK, INC. | Reduced | 7.8M | May 13, 2026 |
| CITIGROUP INC | Increased | 5.2M | Feb 13, 2026 |
| CITIGROUP INC | Reduced | 5.1M | May 11, 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | New Position | 4.7M | May 8, 2026 |
| STATE STREET CORP | Increased | 4.5M | May 15, 2026 |
| MORGAN STANLEY | Increased | 3.9M | Feb 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 3.8M | May 15, 2026 |
| MAVERICK CAPITAL LTD | Increased | 3.6M | May 15, 2026 |
| NEWTYN MANAGEMENT, LLC | Increased | 3.2M | May 15, 2026 |
| NUVEEN, LLC | Increased | 3.1M | Apr 30, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 3.1M | May 15, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.